Morbidity from hepatitis B after introduction of nationwide immunisation in Italy.
Squarcione
S
S
Pompa
M G
MG
Vellucci
L
L
D000293:Adolescent; D000328:Adult; D016907:Adverse Drug Reaction Reporting Systems; D002648:Child; D002675:Child, Preschool; D004168:Diphtheria Toxoid / Q000009:adverse effects; D022422:Diphtheria-Tetanus Vaccine; D015721:Diphtheria-Tetanus-Pertussis Vaccine / Q000009:adverse effects; D006509:Hepatitis B / Q000453:epidemiology* / Q000517:prevention & control; D017325:Hepatitis B Vaccines / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D007114:Immunization / Q000331:legislation & jurisprudence / Q000706:statistics & numerical data; D007223:Infant; D007231:Infant, Newborn; D007558:Italy / Q000453:epidemiology; D011159:Population Surveillance; D013745:Tetanus Toxoid / Q000009:adverse effects; D014611:Vaccination / Q000706:statistics & numerical data; D017778:Vaccines, Combined / Q000009:adverse effects
D004168:Diphtheria Toxoid; D022422:Diphtheria-Tetanus Vaccine; D015721:Diphtheria-Tetanus-Pertussis Vaccine; D017325:Hepatitis B Vaccines; D013745:Tetanus Toxoid; D017778:Vaccines, Combined